HealthLeaders Media January 22, 2025
Eric Wicklund

Healthcare executives are calling on the Trump Administration to nullify a DEA proposal to create a special registration for virtual prescribing of controlled drugs, saying the proposed rule ‘would be a major setback.’

KEY TAKEAWAYS

– After a 17-year delay, the DEA last week unveiled a proposal to create a special registration for providers wanting to prescribe controlled drugs via telemedicine.

– Telehealth advocates, who have long pressured the DEA and lawmakers to create that registration process, say the proposed rule is burdensome and overly complicated.

– They’re now calling on the Trump Administration to withdraw the proposed rule, with the hope that the DEA will work with advocates on a new version.

Healthcare executives who have lobbied the U.S....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Digital Health, Govt Agencies, Provider, Technology, Telehealth
6 tips for starting an RPM program
Why Teladoc Health is Acquiring Catapult Health for $65M
Calif. Farmworkers Use Telehealth to Reach Mexican Doctors
'A gap in the literature': Why Ascension aims to diversify telehealth
Teladoc Pays $65 Million to Acquire Catapult Health

Share This Article